Aberrant Expression of MicroRNA-15a and MicroRNA-16 Synergistically Associates with Tumor Progression and Prognosis in Patients with Colorectal Cancer

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  Xiao, Guangfa ^a   Tang, Huihuan ^a   Wei, Wei ^a   Li, Jian ^a   Ji, Liandong ^a   Ge, Jie ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 15A; MICRORNA 16;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOLOGY; PROTEIN EXPRESSION;

EID: 84934968132     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/364549     Document Type: Article

References (23)

1. Ö. Akgül, E. Çetinkaya, Ş. Ersöz, and M. Tez, "Role of surgery in colorectal cancer liver metastases," World Journal of Gastroenterology, vol. 20, no. 20, pp. 6113-6122, 2014.
2. A. S. Walker, E. K. Johnson, J. A. Maykel et al., "Future directions for the early detection of colorectal cancer recurrence," Journal of Cancer, vol. 5, no. 4, pp. 272-280, 2014.
3. M. Sridharan, J. M. Hubbard, and A. Grothey, "Colorectal cancer: how emerging molecular understanding affects treatment decisions," Oncology, vol. 28, pp. 110-118, 2014.
4. S. Dattatreya, "Metastatic colorectal cancer-prolonging overall survival with targeted therapies," South Asian Journal of Cancer, vol. 2, pp. 179-185, 2013.
5. M. Thorsteinsson and P. Jess, "The clinical significance of circulating tumor cells in non-metastatic colorectal cancer - a review," European Journal of Surgical Oncology, vol. 37, no. 6, pp. 459-465, 2011.
6. V. Ambros, "MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing," Cell, vol. 113, no. 6, pp. 673-676, 2003.
7. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function," Cell, vol. 116, no. 2, pp. 281-297, 2004.
8. V. Ambros, "The functions of animal microRNAs," Nature, vol. 431, no. 7006, pp. 350-355, 2004.
9. S. Ak, B. Tunca, G. Tezcan et al., "MicroRNA expression patterns of tumors in early-onset colorectal cancer patients," Journal of Surgical Research, vol. 191, no. 1, pp. 113-122, 2014.
10. J. Wang, S.-K. Huang, M. Zhao et al., "Identification of a circulating microRNA signature for colorectal cancer detection," PLoS ONE, vol. 9, no. 4, Article ID e87451, 2014.
11. G. A. Calin, A. Cimmino, M. Fabbri et al., "MiR-15a and miR-16-1 cluster functions in human leukemia," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 13, pp. 5166-5171, 2008.
12. R. I. Aqeilan, G. A. Calin, and C. M. Croce, "MiR-15a and miR-16-1 in cancer: discovery, function and future perspectives," Cell Death and Differentiation, vol. 17, no. 2, pp. 215-220, 2010.
13. Q. Luo, X. Li, J. Li et al., "MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer," International Journal of Oncology, vol. 43, no. 4, pp. 1212-1218, 2013.
14. N. Bandi and E. Vassella, "MiR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner," Molecular Cancer, vol. 10, article 55, 2011.
15. Y.-H. Huang, K.-H. Lin, H.-C. Chen et al., "Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma," PLoS ONE, vol. 7, no. 5, Article ID e37188, 2012.
16. M. Musumeci, V. Coppola, A. Addario et al., "Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer," Oncogene, vol. 30, no. 41, pp. 4231-4242, 2011.
17. Q. Ma, X. Wang, Z. Li et al., "MicroRNA-16 represses colorectal cancer cell growth in vitro by regulating the p53/survivin signaling pathway," Oncology Reports, vol. 29, no. 4, pp. 1652-1658, 2013.
18. J. Qian, B. Jiang, M. Li, J. Chen, and M. Fang, "Prognostic significance of microRNA-16 expression in human colorectal cancer," World Journal of Surgery, vol. 37, no. 12, pp. 2944-2949, 2013.
19. L. Dai, W. Wang, S. Zhang et al., "Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo," Cell Biology International, vol. 36, no. 8, pp. 765-770, 2012.
20. L. Shi, R. Jackstadt, H. Siemens, H. Li, T. Kirchner, and H. Hermeking, "P53-induced miR-15a/16-l and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer," Cancer Research, vol. 74, no. 2, pp. 532-542, 2014.
21. R. Bhattacharya, M. Nicoloso, R. Arvizo et al., "MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer," Cancer Research, vol. 69, no. 23, pp. 9090-9095, 2009.
22. C. Y. Sun, X. M. She, Y. Qin et al., "miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF," Carcinogenesis, vol. 34, no. 2, pp. 426-435, 2013.
23. D. Bonci, V. Coppola, M. Musumeci et al., "The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities," Nature Medicine, vol. 14, no. 11, pp. 1271-1277, 2008.